Table 4.
Overall (N = 6,751) | Vaccinated (N = 3,199) | Before Vaccination (N = 3,552) | p-Value | |
---|---|---|---|---|
Coronary artery disease* | 12.9% | 13.3% | 12.6% | 0.352 |
Congestive heart failure | 12.2% | 12.0% | 12.4% | 0.684 |
Conduction abnormalities | 12.7% | 13.4% | 12.1% | 0.108 |
Valvular heart disease | 3.9% | 3.8% | 3.80% | 0.668 |
Pericarditis | 0.52% | 0.53% | 0.51% | 0.888 |
Myocarditis | 0.04% | 0.06% | 0.03% | 0.504 |
Hypertension without complications | 42.6% | 43.6% | 41.8% | 0.124 |
Hypertension with complications | 12.9% | 12.7% | 13.1% | 0.577 |
Hypotension | 3.5% | 3.6% | 3.4% | 0.580 |
Peripheral vascular disease | 6.8% | 6.7% | 7.0% | 0.630 |
Hyperlipidemia | 27.1% | 28.7% | 25.7% | 0.006 |
Neurologic | ||||
Cerebrovascular event | 3.5% | 3.8% | 3.2% | 0.250 |
Neurological disorder | 13.3% | 12.5% | 13.9% | 0.083 |
Peripheral neuropathy | 8.2% | 8.1% | 8.4% | 0.692 |
Pulmonary | ||||
Pulmonary embolism | 0.8% | 0.7% | 0.8% | 0.542 |
Chronic lung disease | 21.7% | 21.9% | 21.5% | 0.667 |
Pulmonary hypertension | 2.7% | 2.7% | 2.8% | 0.743 |
Respiratory infection | 7.1% | 5.5% | 8.5% | <0.001 |
Gastrointestinal | ||||
Obesity | 9.2% | 8.9% | 9.4% | 0.507 |
Metabolic disorder | 4.8% | 4.7% | 4.9% | 0.732 |
Malnutrition | 2.5% | 2.4% | 2.6% | 0.580 |
Upper GI disorders | 10.8% | 10.6% | 11.0% | 0.584 |
Lower GI disorders | 0.8% | 0.8% | 0.9% | 0.496 |
Liver/gallbladder disease | 4.4% | 4.4% | 4.4% | 0.975 |
Pancreatic disease | 1.6% | 1.6% | 1.5% | 0.880 |
GI bleed | 2.1% | 1.8% | 2.3% | 0.177 |
Hematological | ||||
Anemia | 1.1% | 1.1% | 1.0% | 0.746 |
Coagulopathy | 2.8% | 2.8% | 2.8% | 0.879 |
White blood cell disorder | 5.8% | 5.5% | 6.0% | 0.443 |
Genitourinary | ||||
Renal disease | 19.1% | 19.0% | 19.1% | 0.885 |
Electrolyte abnormalities | 17.2% | 16.8% | 17.5% | 0.490 |
Urinary disorders | 5.7% | 5.5% | 5.9% | 0.439 |
Urologic disorders | 4.1% | 4.1% | 4.0% | 0.789 |
Gynecological disorders | 2.9% | 3.0% | 2.8% | 0.758 |
Pregnancy | 0.8% | 1.0% | 0.6% | 0.104 |
Other | ||||
Musculoskeletal disorders | 32.5% | 33.7% | 31.5% | 0.055 |
Diabetes | 24.9% | 24.7% | 25.1% | 0.732 |
Trauma | 15.5% | 15.9% | 15.9% | 0.360 |
Substance abuse | 12.0% | 10.5% | 13.4% | <0.001 |
Infection | 11.0% | 10.2% | 11.7% | 0.045 |
Psychiatric disorders | 10.0% | 9.1% | 10.9% | 0.014 |
Thyroid disease | 8.4% | 8.8% | 8.1% | 0.279 |
Malignancy | 6.6% | 7.0% | 6.3% | 0.214 |
Eyes, ears, nose and throat disorders | 6.5% | 6.5% | 6.5% | 0.919 |
Toxins | 5.4% | 6.5% | 4.3% | <0.001 |
Skin disorders | 4.5% | 4.7% | 4.3% | 0.416 |
Autoimmune disorders | 1.3% | 1.4% | 1.2% | 0.356 |
Allergic reaction | 1.4% | 1.9% | 0.9% | <0.001 |
Boldface type denotes statistical significance. GI = gastrointestinal; SD = standard deviation.
Includes acute coronary syndrome.